Kallyope | Cosign

Cosign

A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.

Team

Profile nameProfile nameProfile name

Team

Profile nameProfile nameProfile name

Cosigns Received

Cosigner name

A thoughtful collaborator who builds great products and supports the people around them.

Profile name

Cosigner name

A thoughtful collaborator who builds great products and supports the people around them.

Profile name

A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.

Team

Profile nameProfile nameProfile name

Team

Profile nameProfile nameProfile name

Cosigns Received

Cosigner name

A thoughtful collaborator who builds great products and supports the people around them.

Profile name

Cosigner name

A thoughtful collaborator who builds great products and supports the people around them.

Profile name

Kallyope At Kallyope, we are leveraging unique insights into neural signaling pathways and developing innovative medicines for the treatment of migraine. Our late-stage pipeline focuses on delivering an effective, easy to use, first-in-class medication. Kallyope was founded by world-leading neuroscientists whose groundbreaking research into previously unexplored neural networks is now being carried forward by a team of experienced drug developers. Elismetrep, our lead asset being developed for the acute treatment of migraine, is in Phase 3.

Cosigns

Team

Jobs

A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.

Team

Profile nameProfile nameProfile name

Team

Profile nameProfile nameProfile name

Cosigns Received

Cosigner name

A thoughtful collaborator who builds great products and supports the people around them.

Profile name

Cosigner name

A thoughtful collaborator who builds great products and supports the people around them.

Profile name

Kallyope | Cosign